-+ 0.00%
-+ 0.00%
-+ 0.00%

SANGAMO THERAPEUTICS: ST-920 STUDY PIVOTAL DATA READOUT EXPECTED BY END OF Q2 2025

Reuters·05/06/2025 12:31:33

Please log in to view news